Literature DB >> 15085909

Testing subject comprehension of utility questionnaires.

Deborah G Dobrez1, Elizabeth A Calhoun.   

Abstract

Utility questionnaires are often considered difficult for subjects to understand. Our study reports pilot testing of two subject comprehension tests to determine whether comprehension can be directly measured. Current health utilities were assessed using the standard gamble (SG), time trade-off (TTO), and visual analog scale. Subjects were randomized to one of two tests: (1) Logical consistency was tested by comparing rankings of two health states with an investigator-assigned a priori ranking; (2) Utility responses for two hypothetical respondents were presented; the subject was asked who had the better health. Thirty-one subjects completed the SG and TTO for two health states: being blind and wearing glasses. No subjects had inconsistent rankings. Post hoc analyses found that subjects reporting utilities below the first decile for the state, wearing glasses, had significantly lower current health utility than remaining subjects. Of the thirty subjects who evaluated the hypothetical respondents' utilities, five incorrectly judged the respondent with worse utility to have better health. Those subjects also reported current health utilities significantly lower than the remaining subjects. Our study findings suggest that a minority should be expected to have difficulty completing utility questionnaires. Comprehension checks may improve the reliability of utility data by enhancing training and by identifying subjects who may have misunderstood the utility questions.

Mesh:

Year:  2004        PMID: 15085909     DOI: 10.1023/B:QURE.0000018475.17665.6e

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  12 in total

1.  Differences in health values among patients, family members, and providers for outcomes in schizophrenia.

Authors:  L A Lenert; J Ziegler; T Lee; R Sommi; R Mahmoud
Journal:  Med Care       Date:  2000-10       Impact factor: 2.983

2.  The comparability and reliability of five health-state valuation methods.

Authors:  P F Krabbe; M L Essink-Bot; G J Bonsel
Journal:  Soc Sci Med       Date:  1997-12       Impact factor: 4.634

3.  The effect of assessment method and respondent population on utilities elicited for Gaucher disease.

Authors:  A E Clarke; M K Goldstein; D Michelson; A M Garber; L A Lenert
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

Review 4.  Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.

Authors:  D A Revicki; R M Kaplan
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

5.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

6.  Assessing values for health: numeracy matters.

Authors:  S Woloshin; L M Schwartz; M Moncur; S Gabriel; A N Tosteson
Journal:  Med Decis Making       Date:  2001 Sep-Oct       Impact factor: 2.583

7.  The role of numeracy in understanding the benefit of screening mammography.

Authors:  L M Schwartz; S Woloshin; W C Black; H G Welch
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

8.  A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.

Authors:  C L Bennett; G Chapman; A S Elstein; S J Knight; R B Nadler; R Sharifi; T Kuzel
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

9.  Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists.

Authors:  E A Calhoun; C L Bennett; P A Peeples; J R Lurain; P Y Roland; J M Weinstein; D A Fishman
Journal:  Gynecol Oncol       Date:  1998-12       Impact factor: 5.482

10.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

View more
  4 in total

1.  Measuring utilities by the time trade-off method in Tunisian rheumatoid arthritis patients.

Authors:  Ismail Bejia; Kamel Ben Salem; Mongi Touzi; Naceur Bergaoui
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

2.  A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia.

Authors:  Chandra Bala; Paul Athanasiov; Jason Holland; Mukesh Dhariwal; Amit Gupta; Hemant Rathi
Journal:  Clin Ophthalmol       Date:  2022-08-02

3.  Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.

Authors:  Ayse Kuspinar; Simon Pickard; Nancy E Mayo
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

Review 4.  The impact of acute pneumococcal disease on health state utility values: a systematic review.

Authors:  Ryan O'Reilly; Sayako Yokoyama; Justin Boyle; Jeffrey C Kwong; Allison McGeer; Teresa To; Beate Sander
Journal:  Qual Life Res       Date:  2021-07-17       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.